1. Lyon (France): International Agency for Research on Cancer; 2022, WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours, vol. (WHO classification of tumours series, 5th ed.; 10). [Online]. Available: https://tumourclassification.iarc.who.int/chapters/53.
2. A 5-decade analysis of 13,715 carcinoid tumors;Modlin IM;Cancer,2003
3. N. S. Reed et al., “Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary,” Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S35-41, Nov. 2014, doi: 10.1097/IGC.0000000000000265.
4. Lyon (France): International Agency for Research on Cancer; 2020, WHO Classification of Tumours Editorial Board. Female genital tumours, vol. (WHO classification of tumours series, 5th ed.; 4). [Online]. Available: https://tumourclassification.iarc.who.int/chapters/34.
5. J. Soga, M. Osaka, and Y. Yakuwa, “Carcinoids of the ovary: an analysis of 329 reported cases,” J Exp Clin Cancer Res, vol. 19, no. 3, pp. 271–280, Sep. 2000.